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Abstract
Despite eliciting a potent CD8+ T cell response, Brucella abortus is able to persist and
establish a chronic infection inside its host. We have previously reported that the infection
of human monocytes/macrophages with B. abortus inhibits the IFN-γ-induced MHC-I cell
surface expression down-modulating cytotoxic CD8+ T cell responses. MHC-I down-mod-
ulation depends on bacterial viability and results from the capacity of B. abortus to retain
the MHC-I molecules within the Golgi apparatus. Furthermore, we recently demonstrated
that epidermal growth factor receptor (EGFR) pathway is involved in this phenomenon and
that this is an early event during infection. However, the components and mechanisms
whereby B. abortus is able to down-modulate MHC-I remained to be elucidated. In this
study we demonstrated that the down-modulation of MHC-I expression is not mediated by
well-known Brucella virulence factors but instead by B. abortus RNA, a PAMP associated
to viability (vita-PAMP). Surprisingly, completely degraded RNA was also able to inhibit
MHC-I expression to the same extent as intact RNA. Accordingly, B. abortus RNA and its
degradation products were able to mimic the MHC-I intracellular retention within the Golgi
apparatus observed upon infection. We further demonstrated that TLR8, a single-stranded
RNA and RNA degradation products sensor, was involved in MHC-I inhibition. On the
other hand, neutralization of the EGFR reversed the MHC-I inhibition, suggesting a con-
nection between the TLR8 and EGFR pathways. Finally, B. abortus RNA-treated macro-
phages display diminished capacity of antigen presentation to CD8+ T cells. Overall, our
results indicate that the vita-PAMP RNA as well as its degradation products constitute
novel virulence factors whereby B. abortus, by a TLR8-dependent mechanism and
through the EGFR pathway, inhibits the IFN-γ-induced MHC-I surface expression on
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human monocytes/macrophages. Thus, bacteria can hide within infected cells and avoid
the immunological surveillance of cytotoxic CD8+ T cells.
Author summary
Brucella abortus is one of the intracellular bacterial species that cause brucellosis, a zoo-
notic worldwide disease. An intricate enigma of Brucella immunity is its long-term persis-
tence inside host despite a vigorous and specific immune response. Our study describes a
novel immune evasion strategy exploited by B. abortus: the down-modulation of the IFN-
γ-induced expression of the molecules responsible for antigen presentation to CD8+ T
cells on the surface of monocytes, Major Histocompatibility Complex Class I (MHC-I)
molecules. We found that the bacterial component responsible for this phenomenon is its
RNA, a component associated with bacterial viability itself. Specifically, we demonstrated
that not only does intact RNA down-modulate MHC-I but also the RNA degradation
products. Bacterial RNA is sensed by pattern recognition receptors (PRRs), among which
TLRs family has gained more attention. In this study, we demonstrated that the receptor
involved in this phenomenon is TLR8, a single-stranded RNA and RNA degradation
products sensor. By means of this mechanism, Brucella impairs antigen presentation to
CD8+ T cells, hiding within infected cells and avoiding the immunological surveillance of
cytotoxic cells. On balance, these results provide new evidence to understand how B. abor-
tus can survive inside the host and persist chronically.
Introduction
Host control of brucellosis requires a set of cells and components of the immune system which
together promote a complex response against Brucella spp. [1]. Yet, from the many defensive
resources that adaptive immunity brings into play, cytotoxic CD8+ T cells are determinant to
restrain Brucella infection. The importance of these cells resides in their capacity to eliminate
Brucella-infected target cells [2, 3]. Previous studies in humans, mice and bovines have shown
that specific CD8+ T cells are developed during Brucella infection [1, 4], confirming the ability
of Brucella-infected macrophages to present bacterial antigens on MHC-I molecules and acti-
vate cytotoxic CD8+ T cell responses. Despite this immune response, Brucella is able to persist
inside these cells establishing a chronic infection. Therefore, as a successful chronic and persis-
tent pathogen, Brucella must own an effective strategy to subvert the challenge of highly outfit-
ted CD8+ T cells. We have previously reported that infection of human monocytes/
macrophages with B. abortus inhibits the IFN-γ-induced MHC-I cell surface expression. As a
consequence, B. abortus-infected macrophages display diminished capacity of antigen presen-
tation to CD8+ T cells [5]. MHC-I down-modulation results from the capacity of B. abortus to
induce the retention of these molecules within the Golgi apparatus [5]. However, the compo-
nents of B. abortus involved in this phenomenon remained unknown.
Interestingly, B. abortus-mediated MHC-I down-modulation is dependent on bacterial via-
bility as was demonstrated by the incapacity of heat-killed bacteria to inhibit the expression of
such molecules [5]. Furthermore, we have recently reported that two B. abortus mutant strains
devoid of key virulence factors, B. abortus RB51 (a rough LPS mutant) and B. abortus virB10-
(a VirB type IV secretion system mutant), are capable of inhibiting the IFN-γ-induced MHC-I
surface expression to the same extent as wild-type B. abortus [6]. These B. abortus mutant
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strains are unable to persist inside human monocytes for a long period despite their preserved
capacity of infecting cells [7–9]. Consistent with this, we observed that the phenomenon of
MHC-I inhibition is triggered at early time points and can be observed at 8 h post-infection.
At 24 h and 48 h post-infection it became even stronger [6]. Overall these results led us to
think that the components involved in the inhibition of IFN-γ-induced MHC-I surface expres-
sion should be associated with bacterial viability. In turn, our results with the mutant strains
gave us the idea that these bacterial components should be expressed early during infection.
It has been recently demonstrated that the immune system is capable of sensing the most
essential characteristic of microbial infectivity, microbial viability itself [10]. The immune sys-
tem can thus detect pathogen-associated molecular patterns (PAMPs) which are present in
live bacteria but rapidly eliminated when bacteria lose their viability [10]. These PAMPs are
lost since they are intimately linked to the metabolic activity and replicative capacity of the
microorganisms. In order to differentiate them from traditional PAMPs, structural compo-
nents that are preserved after loss of bacterial viability (such as LPS, lipoproteins and DNA,
among others), this special class of PAMPs were named viability-associated PAMPs (vita-
PAMPs), among which prokaryotic RNA is included [10, 11].
Recognition of nucleic acids in general and RNA in particular by receptors of the innate
immune system is a complicated and interesting field of investigation. The immune system
must discriminate between ‘self’ (host) and ‘foreign’ (invading pathogen) nucleic acids [12].
This principle is based on three criteria: the availability of nucleic acid ligands, the localization
of such nucleic acids and their structure (characterized by sequence motifs, conformation and
chemical modification). In most cases, a combination of these aspects contributes to the
proper recognition of foreign nucleic acids and the induction of adequate immune responses
[12]. Most of the receptors involved in the immune sensing of nucleic acids have been identi-
fied. Among them, the TLRs located in endosomes/phagolysosomes are the most studied:
TLR9 senses CpG DNA motifs; TLR3 and TLR7 are capable of recognizing double-stranded
and single-stranded RNA respectively and TLR8 is not only able to recognize single-stranded
RNA but it has been recently described as a RNA degradation products sensor as well [13, 14].
Taking our previous results into account, we hypothesized that the components of B. abor-
tus involved in the inhibition of MHC-I could be vita-PAMPs such as B. abortus RNA, since
they are found exclusively in live bacteria and are actively expressed during early stages of
infection. Thus, the aim of this study was to characterize the components, signaling pathways
and mechanisms implicated in MHC-I down-modulation. Overall, our results indicate that
the vita-PAMP RNA as well as its degradation products constitute novel virulence factors
whereby B. abortus, by a TLR8-dependent mechanism and through the EGFR pathway, inhib-
its the IFN-γ-induced MHC-I surface expression on human monocytes/macrophages.
Results
The inhibition of MHC-I surface expression mediated by B. abortus is
dependent on bacterial viability but independent of its clue virulence
factors
Our previous results had demonstrated that B. abortus-mediated MHC-I inhibition is depen-
dent on bacterial viability [5]. On the other hand, we have recently reported that B. abortus
rough LPS mutant RB51 and a mutant in the B. abortus type IV secretion system VirB, two
mutant strains in key virulence factors, are capable of inhibiting the IFN-γ-induced MHC-I
surface expression to the same extent as wild-type B. abortus [6]. These results led us to think
that human monocytes/macrophages could be able to detect a component associated with bac-
terial viability independently of its virulence factors. In order to address this hypothesis, we
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used different B. abortus mutant strains on key virulence factors and evaluated whether their
live and heat-killed (HK) forms could inhibit the IFN-γ-induced MHC-I surface expression on
THP-1 cells. The mutant strains used were: RB51 (rough LPS mutant), virB10- (mutant in
VirB type IV secretion system), btpA, btpB single mutants and a btpAbtpB double mutant
(mutants of TIR domain-containing proteins which interfere with TLRs signaling pathways),
and Bpe159 (mutant in B. abortus putative effector protein BPE159, which is secreted into the
host cytosol independently of the VirB secretion system [15]). Confirming and extending our
previous results, B. abortus S2308 (wild type, WT) and all mutant strains studied were able to
diminish the IFN-γ-induced MHC-I surface expression in a dose-dependent manner after 48
h. However, this phenomenon occurred exclusively when bacteria were alive (Fig 1A–1E and
S1 Fig, Panels i and iii). The heat-killed forms of these bacteria lost the capacity of inhibiting
MHC-I, even at the highest concentration used (1 x 109 bacteria/ml) (Fig 1A–1E and S1 Fig,
Panels ii and iv). These results confirm that the inhibition of MHC-I surface expression is
dependent on B. abortus viability but independent of the studied virulence factors. In addition,
these results suggest that MHC-I inhibition is not caused by B. abortus structural components,
which are conserved in heat-killed bacteria. To corroborate our results, we next studied the
effect of different structural components of B. abortus on MHC-I surface expression, such as:
B. abortus lipopolysaccharide (Ba LPS); its outer membrane protein 19 (Omp19), a prototypi-
cal lipoprotein of B. abortus, on its lipidated (L-Omp19) and unlipidated (U-Omp19) versions
and B. abortus DNA (Ba DNA). None of the evaluated structural components was able to
inhibit the IFN-γ-induced MHC-I surface expression (Fig 2A and 2B). Overall, these results
confirm that B. abortus-mediated inhibition of MHC-I surface expression requires bacterial
viability regardless of the presence of more specialized factors that regulate microbial viru-
lence. In addition, they show that the bacterial component involved in this phenomenon
seems to be associated with bacterial viability.
B. abortus RNA is the vita-PAMP involved in the inhibition of MHC-I
expression
Prokaryotic RNA has been recently characterized as a special class of viability-associated
PAMP (vita-PAMP), as it is present only in viable bacteria [10]. To investigate whether B.
abortus RNA was the component involved in the inhibition of MHC-I surface expression on
human monocytes, we used B. abortus WT RNA to stimulate THP-1 cells in the presence of
IFN-γ for 48 h at different concentrations. The expression of MHC-I was then evaluated by
flow cytometry. B. abortus WT RNA significantly down-regulated the IFN-γ-induced surface
expression of MHC-I molecules in a dose-dependent manner (Fig 3A), mimicking what was
previously observed with viable B. abortus. Given that certain phenol traces could still be pres-
ent in the purified RNA, we performed the RNA extraction in the absence of bacteria and used
it as control (TRIzol bar). This treatment was not able to down-modulate MHC-I (Fig 3A).
Moreover, RNA purified with a method other than TRIzol was equally able to inhibit MHC-I
expression on THP-1 cells (S2 Fig). In turn, RNA purified from the mutant strains RB51 and
virB10 was also able to inhibit the IFN-γ-induced MHC-I surface expression on THP-1 cells to
the same extent as B. abortus WT RNA (Fig 3B and 3C). This inhibition was not due to a loss
of cell viability in B. abortus RNA stimulated cultures, since MHC-I inhibition was observed
gating only on viable cells (7-AAD negative cells). Furthermore, B. abortus RNA treatment did
not induce early and late apoptosis or necrosis as determined by the Annexin V assay, even at
the highest evaluated concentration (10 μg/ml) (Fig 3D). On the contrary, high levels of early
and late apoptosis or necrosis were obtained on cells treated with the positive control parafor-
maldehyde (PFA).
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In agreement with the inability of heat-killed B. abortus (HKBA) to inhibit MHC-I surface
expression, we determined by gel electrophoresis that HKBA lacked RNA and that the prod-
ucts recovered from the HKBA RNA extraction process were unable to inhibit MHC-I surface
expression (S3 Fig). Moreover, B. abortus RNA was able to complement the absence of this
Fig 1. Only viable B. abortus, independently of its virulence factors, is able to inhibit MHC-I expression. (A-E,
Panels i and iii) THP-1 cells were infected with B. abortus WT (A), btpA (B), btpB (C), btpAbtpB (D) and Bpe159 (E) at
different MOI in the presence of IFN-γ for 2 h, washed and cultured in the presence of IFN-γ for 48 h. (A-E, Panels ii and iv)
At the same time, heat-killed (HK) bacteria were used to treat THP-1 cells in the presence of IFN-γ for 48 h. MHC-I
expression was assessed by flow cytometry. Bars represent the arithmetic means ± SEM of five experiments. MFI, mean
fluorescence intensity. **P<0.01; ***P<0.001 vs. IFN-γ-treated.
https://doi.org/10.1371/journal.ppat.1006527.g001
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molecule in HKBA, making it capable of down-modulating MHC-I expression on human
monocytes (S4 Fig). In another set of experiments, THP-1 cells were stimulated with B. abortus
RNA alone or introduced into the cell by transfection with lipofectamine reagent. Stimulation
with B. abortus RNA, independently of the procedure, was able to inhibit MHC-I expression
Fig 2. B. abortus structural components do not down-modulate the IFN-γ-induced MHC-I expression on THP-1
cells. (A and B) THP-1 cells were treated with different doses of B. abortus LPS, L-Omp19, U-Omp19 or DNA in the
presence of IFN-γ for 48 h. MHC-I expression was assessed by flow cytometry. Bars indicate the arithmetic means ± SEM
of five independent experiments. MFI, mean fluorescence intensity.
https://doi.org/10.1371/journal.ppat.1006527.g002
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Fig 3. B. abortus RNA inhibits MHC-I expression and this does not involve loss of cell viability. (A) THP-1 cells
were treated with different doses of B. abortus WT RNA in the presence of IFN-γ for 48 h. THP-1 cells treated with TRIzol
extracted products in the absence of bacteria were used as a control. (B and C) THP-1 cells were treated with different
doses of RB51 (B) and virB10- (C) RNAs in the presence of IFN-γ for 48 h. MHC-I expression was assessed by flow
cytometry. (D) THP-1 cells treated with different doses of B. abortus WT RNA in the presence of IFN-γ for 48 h were
stained with Annexin V-FITC and Propidium Iodide (PI) and then analyzed for early Apoptosis (Annexin V+/PI-), late
apoptosis (Annexin V+/PI+) and necrosis (Annexin V-/PI+). Cells treated with Paraformaldehyde (PFA) were used as a
positive control. (E and F) THP-1 cells were transfected with B. abortus WT RNA with lipofectamine or treated with B.
B. abortus RNA inhibits MHC-I
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suggesting that RNA without transfection could gain access to endosomal sensors (3E and F).
Confirming these results, the endocytosis inhibitor Nystatin was able to reverse MHC-I inhibi-
tion mediated by stimulation with B. abortus RNA (S5 Fig). On the other hand, other prokary-
otic RNAs (from Bacillus cereus, Salmonella typhimurium, Escherichia coli and Klebsiella
pneumonia) were able to inhibit MHC-I surface expression. On the contrary, eukaryotic RNA
(from peripheral blood mononuclear cells, PBMCs) was unable to inhibit MHC-I surface
expression, even at the highest concentration utilized (S6 Fig). Overall, these results indicate
that RNA is a component associated with bacterial viability which is employed by B. abortus to
inhibit the IFN-γ-induced surface expression of MHC-I molecules on human monocytes.
More importantly, this is not an exclusive phenomenon of B. abortus RNA as it could be
extended to other prokaryotic although not to eukaryotic RNAs.
B. abortus RNA degradation products are also able to inhibit the IFN-γ-
induced expression of MHC-I
As traces of DNA and proteins could contaminate the RNA fractions, we decided to further
purify our preparations of B. abortus RNA by eliminating either residual DNA or proteins. For
this, B. abortus RNA fractions were digested with a DNase or a proteinase (Proteinase K; PK).
After that, we verified that the treatments with the enzymes had not affected the integrity of
the RNA (Fig 4A, lane 3 and 4). The products of such digestions were then employed to stimu-
late THP-1 cells in the presence of IFN-γ for 48 h. Then, the expression of MHC-I molecules
was evaluated by flow cytometry. The preparations of DNase- and PK-digested RNA were still
able to inhibit MHC-I expression in the same manner as intact RNA, indicating that contami-
nating DNA and proteins do not mediate the phenomenon of MHC-I inhibition (Fig 4B and
4C). B. abortus RNA was next digested with a prokaryotic RNA-specific RNase and this prod-
uct was employed to stimulate THP-1 cells in the presence of IFN-γ for 48 h. The RNase used
was RNase I from Escherichia coli which degrades single-stranded RNA in a mixture of mono-,
di-, and tri-nucleotides. RNA preparations digested with RNase I completely lost the integrity
of the RNA (Fig 4A, lane 5). Surprisingly, products from RNase I-digested RNA were still able
to inhibit the IFN-γ-induced MHC-I surface expression to the same extent as intact RNA (Fig
4D and 4E). MHC-I down-modulation was not due to the presence of the RNase in the culture,
since the negative control with merely RNase I was unable to reproduce the phenomenon.
Overall, these results indicate that B. abortus RNA and its degradation products are the com-
ponents involved in the inhibition of IFN-γ-induced MHC-I surface expression.
B. abortus RNA down-modulates MHC-I in peripheral blood-isolated
human monocytes and murine bone marrow-derived macrophages
While THP-1 cells are a good model of human monocytes, we next evaluated whether our
results could be extended to primary cultures of monocytes/macrophages. For this purpose,
peripheral blood-isolated human monocytes or murine bone marrow-derived macrophages
(BMM) were stimulated with different concentrations of B. abortus RNA and then the expres-
sion of MHC-I molecules was evaluated by flow cytometry. B. abortus RNA was significantly
able to inhibit MHC-I expression in both human primary monocytes and murine BMM in a
abortus WT RNA in the presence of IFN-γ for 48 h. MHC-I was assessed by flow cytometry. Bars represent the arithmetic
means ± SEM of five experiments. MFI, mean fluorescence intensity. *P<0.05; **P<0.01; ***P<0.001 vs. IFN-γ-treated.
###P<0.001 vs. untreated.
https://doi.org/10.1371/journal.ppat.1006527.g003
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Fig 4. B. abortus RNA degradation products are also capable of inhibiting the IFN-γ-induced expression of MHC-I.
(A) RNA from B abortus was purified and treated with DNase, Proteinase K (PK) or E. coli RNase I. Each treatment was
visualized by 1% agarose gel electrophoresis. (B and C) THP-1 cells were stimulated with DNase (B) or PK (C)–treated B.
abortus RNA in the presence of IFN-γ for 48 h. Cells treated with DNase or PK alone were used as negative controls. Cells
treated with B. abortus RNA were used as positive controls. (D and E) THP-1 cells were treated with RNase I-treated B.
abortus RNA in the presence of IFN-γ for 48 h. Cells treated only with RNase I were used as negative controls. Cells
treated with B. abortus RNA were used as positive controls. MHC-I was assessed by flow cytometry. Bars represent the
arithmetic means ± SEM of five experiments. MFI, mean fluorescence intensity. *P<0.05; **P<0.01; ***P<0.001 vs. IFN-
γ-treated. ##P<0.01; ###P<0.001 vs. negative controls.
https://doi.org/10.1371/journal.ppat.1006527.g004
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dose-dependent manner (Fig 5A and 5B). Thus, B. abortus RNA does not only inhibit MHC-I
expression on THP-1 cells but also on human primary monocytes and murine macrophages.
MHC-I down-modulation by B. abortus RNA on human monocytes is
TLR8-mediated and involves the EGFR pathway
The most known receptors capable of detecting RNA are TLRs located in endosomes/phagoly-
sosomes. Among them, TLR3 is capable of recognizing double-stranded RNA, TLR7 is capable
of recognizing single-stranded RNA and TLR8 is also able to recognize single-stranded RNA
and recently it was described as capable of recognizing RNA degradation products [13, 14].
Since the capacity of Brucella RNA to form secondary structures is still unknown and consid-
ering that TLR3 has been implicated in many functions mediated by viral double-stranded
RNAs, we first wanted to evaluate whether TLR3 could be involved in B. abortus RNA-medi-
ated inhibition of MHC-I molecules. TLR3 is the unique TLR that transduces its signal
through the adapter protein TRIF. We therefore evaluated the effect of B. abortus RNA in
BMM from TRIF KO mice. B. abortus RNA was able to inhibit the IFN-γ-induced MHC-I sur-
face expression in BMM from TRIF KO mice to the same extent as in BMM from WT mice
(Fig 6A). To confirm the fact that TLR3 was not involved in the inhibition mediated by B.
abortus RNA we used a TLR3 inhibitor (TLR3/dsRNA Complex Inhibitor). Yet in the presence
of a TLR3 inhibitor, B. abortus RNA down-regulated MHC-I expression confirming that TLR3
is not involved in this phenomenon (Fig 6B). Having discarded the participation of TLR3, we
focused our attention on TLR7 and TLR8. Specific agonists have been described for either
TLR7 or TLR8, or both. We used the human TLR7 (hTLR7) agonist Gardiquimod, the human
TLR7/8 (hTLR7/8) agonist Resiquimod (R848) and the human TLR8 (hTLR8) agonists
Fig 5. B. abortus RNA is able to down-modulate MHC-I on primary cultures of monocytes/macrophages. (A and B) Peripheral
blood-isolated human monocytes (A) and murine bone marrow-derived macrophages (BMM) (B) were treated with different doses of B.
abortus RNA. MHC-I expression was assessed by flow cytometry. Bars represent the arithmetic means ± SEM of five experiments. MFI,
mean fluorescence intensity; mIFN-γ, murine IFN-γ. ***P<0.001 vs. IFN-γ-treated.
https://doi.org/10.1371/journal.ppat.1006527.g005
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Fig 6. B. abortus RNA down-modulates MHC-I on human monocytes via TLR8 and through EGFR pathway. (A)
Murine BMM purified from C57BL/6 WT or TRIF KO mice were stimulated with B. abortus RNA in the presence of IFN-γ for
48 h. (B) THP-1 cells were treated with B. abortus RNA 10 μg/ml in the presence of IFN-γ and hTLR3 inhibitor or vehicle
(dimethyl sulfoxide (DMSO)) for 48 h. (C and D) THP-1 cells were treated with different doses of a hTLR7 agonist,
Gardiquimod (C) or with different doses of a hTLR7 and hTLR8 agonist, R848 (Resiquimod) (D) in the presence of IFN-γ
for 48 h. THP-1 cells (E and F) were treated with different doses of two hTLR8 agonists, ORN06 (E) and ssRNA40 (F) in
the presence of IFN-γ for 48 h. (G) Murine BMM were treated with different doses of ssRNA40 in the presence of mIFN-γ
B. abortus RNA inhibits MHC-I
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ssRNA40/LyoVec and ORN06/LyoVec. Gardiquimod was unable to inhibit the IFN-γ-induced
MHC-I surface expression on THP-1 cells (Fig 6C). However, R848 was able to mimic the
inhibition of MHC-I expression mediated by B. abortus RNA (Fig 6D). These results allowed
us to discard hTLR7 and postulate hTLR8 as a possible receptor. To corroborate this, THP-1
cells were stimulated with the hTLR8 agonists ORN06 and ssRNA40. As shown in Fig 6E and
6F, both ORN06/LyoVec and ssRNA40/LyoVec were able to mimic the effect of B. abortus
RNA on MHC-I surface expression. Although TLR8 is not functional in mice [16], it has been
demonstrated that TLR7 performs its function [17, 18]. Since ssRNA40 is not only an agonist
of hTLR8 but also of murine TLR7 (mTLR7) [17], we evaluated its effect on BMM. Corrobo-
rating our results, ssRNA40 was able to inhibit the expression of MHC-I in BMM (Fig 6G). To
confirm these results BMM from WT or TLR7 KO mice were infected with B. abortus or stim-
ulated with B. abortus RNA. Our results showed that the inhibition of MHC-I surface expres-
sion mediated by B. abortus and B. abortus RNA was abolished in BMM from TLR7 KO mice
(Fig 6H and 6I). Altogether these results demonstrate that the MHC-I inhibition by B. abortus
and its RNA is mediated by hTLR8/mTLR7.
Recently, we have demonstrated that the EGFR pathway is involved in the inhibition of
MHC-I surface expression mediated by B. abortus infection [6]. In order to extend this finding
and taking into account that TLR8 is the receptor involved in the phenomenon of B. abortus
RNA-mediated MHC-I inhibition on human monocytes, we decided to evaluate the connec-
tion between TLR8 and EGFR signaling pathways. For this, THP-1 cells were stimulated with
the hTLR8 agonist ORN06/LyoVec in the presence of an EGFR ligand-blocking antibody
(Cetuximab). Neutralization of the EGFR significantly reversed the inhibition of MHC-I sur-
face expression mediated by ORN06 (Fig 6J). This reversion was not due to a dysfunction of
TLR8 caused by Cetuximab, as the secretion of pro-inflammatory cytokines downstream of
NF-κB was unchanged between Isotype control and Cetuximab-treated cells (S7 Fig). Overall,
our results indicate that B. abortus RNA inhibits the IFN-γ-induced MHC-I surface expression
on human monocytes/macrophages by a TLR8-dependent mechanism and through the EGFR
pathway.
B. abortus RNA and its degradation products induce MHC-I intracellular
retention within the Golgi apparatus
We have previously demonstrated that B. abortus infection induces the intracellular retention
of MHC-I molecules within the Golgi apparatus [5]. Thus, we evaluated whether B. abortus
RNA was able to mimic this phenomenon. For this, the localization of MHC-I molecules was
determined by confocal microscopy in cells infected with B. abortus or stimulated with B. abor-
tus RNA in the presence of IFN-γ for 48 h. MHC-I expression was determined with an anti-
HLA-ABC monoclonal antibody followed by Alexa 546-labelled secondary antibody. At 48 h
of culture, cells treated only with IFN-γ showed MHC-I expression confined predominantly to
the cellular membrane (Fig 7A). On the contrary, both B. abortus-infected monocytes as well
as monocytes treated with B. abortus RNA, showed MHC-I expression restricted to the cellular
interior concomitantly with a marked decrease of MHC-I surface expression (Fig 7A and 7B).
Next, we examined the subcellular localization of retained MHC-I molecules. For this, THP-1
for 48 h. (H and I) Murine BMM from TLR7 KO mice were infected with B. abortus (H) or stimulated with different doses of
B. abortus RNA (I) in the presence of mIFN-γ for 48 h. (J) THP-1 cells were treated with ORN06 (10 μg/ml) in the presence
of IFN-γ and Cetuximab or Isotype control for 48 h. MHC-I expression was assessed by flow cytometry. Bars represent the
arithmetic means ± SEM of five experiments. MFI, mean fluorescence intensity; mIFN-γ, murine IFN-γ. *P<0.05;
**P<0.01; ***P<0.001 vs. IFN-γ-treated. #P<0.05; ##P<0.01; ###P<0.001 vs. WT or Isotype control, accordingly.
https://doi.org/10.1371/journal.ppat.1006527.g006
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Fig 7. B. abortus RNA mimics MHC-I intracellular retention in Golgi apparatus mediated by B. abortus infection. (A) Confocal
micrographs of THP-1 cells infected with B. abortus or treated with B. abortus RNA in the presence of IFN-γ for 48 h. MHC-I expression was
determined with a primary anti-human MHC-I Ab (W6/32) and Alexa 546-labelled secondary Ab (red). (B) Quantification of MHC-I retention.
Data are expressed as percentage of cells with MHC-I retained ± SEM of three independent experiments. The number of cells counted per
experimental group was 200. (C) Confocal micrographs of THP-1 cells treated with B. abortus RNA in the presence of IFN-γ for 48 h. MHC-I
expression was determined with a primary anti-human MHC-I Ab (W6/32) and Alexa 546-labelled secondary Ab (red). Subcellular
localization markers were detected using mAbs specific for EEA1 (early endosomes), LAMP-2 (late endosomes/lysosomes), GM130 (Golgi)
and calnexin (ER) followed by Alexa 488-labelled secondary Ab (green). White arrow shows co-localization (yellow staining). Results are
representative of three independent experiments. (D) Quantification of co-localization of MHC-I with the subcellular compartments. Data are
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cells were treated with B. abortus RNA in the presence of IFN-γ for 48 h. MHC-I was detected
as described previously and the subcellular compartments were detected with specific primary
mAbs followed by Alexa 488-labelled secondary Ab. No colocalization was detected with either
the early endosome marker EEA1, the lysosome marker LAMP-2 or the reticulum endoplas-
mic marker calnexin (Fig 7C). On the contrary, in 50% of the B. abortus RNA-treated mono-
cytes that retained MHC-I, these molecules colocalized with the Golgi apparatus marker
GM130 (Fig 7C and 7D). Taking into account that RNA degradation products were also able
to inhibit the MHC-I surface expression, we next evaluated their capacity to induce intracellu-
lar retention of these molecules. Completely degraded RNA was able to induce the intracellular
retention of MHC-I molecules within the Golgi apparatus to the same extent as intact RNA
(Fig 8). Altogether these results demonstrate that B. abortus RNA and its degradation products
mimic the intracellular retention of MHC-I within the Golgi apparatus observed with B. abor-
tus infection.
B. abortus RNA inhibits macrophages antigen presentation to CD8+ T
lymphocytes via mTLR7
Finally, we evaluated whether the diminished MHC-I surface expression induced by B. abortus
RNA was associated with changes in Ag presentation to MHC-I-restricted CD8+ cytotoxic T
cells. For this, murine BMM from WT and TLR7 KO mice were treated with different doses of
B. abortus RNA in the presence of murine IFN-γ (mIFN-γ) for 48 h, followed by incubation
with OVA peptide (SIINFEKL) and a B3Z T-cell hybridoma specific for OVA-Kb, which car-
ries a β-galactosidase construct driven by NF-AT elements from the IL-2 promoter. BMM
from WT and TLR7 KO mice treated solely with mIFN-γ presented Kb-restricted OVA peptide
efficiently after 6 h and onwards (Fig 9A and 9B), as evidenced by the ability of these cells to
induce LacZ activity in B3Z cells. Treatment of BMM from WT mice with B. abortus RNA (1–
10 μg/ml) in the presence of mIFN-γ significantly inhibited presentation of OVA peptide since
it diminished the response of B3Z cells, compared to mIFN-γ-only treated cells (Fig 9A). How-
ever, treatment of BMM from TLR7 KO mice with B. abortus RNA did not affect antigen pre-
sentation to CD8+ T lymphocytes compared to mIFN-γ-only treated cells (Fig 9B). Taken
together, these results indicate that inhibition of MHC-I expression by B. abortus RNA corre-
lates with diminished Ag presentation to MHC-I-restricted CD8+ cytotoxic T cells. In addi-
tion, our results demonstrate that inhibition of Ag presentation to CD8+ T cells by B. abortus
RNA is mediated by mTLR7.
Methods
Ethics statement
Human monocytes were isolated exclusively from healthy adult blood donors in accordance
with the guidelines of the Ethical Committee of the IMEX Institute. All adult blood donors
provided their informed written consent prior to the study. Mouse bone marrow-derived mac-
rophages (BMM) were generated by differentiation of bone marrow progenitors from female
C57BL/6 mice (aged 2–3 months). Mice were kept under specific pathogen-free conditions in
positive-pressure cabinets and provided with sterile food and water ad libitum. All animal pro-
cedures were performed according to the rules and standards for the use of laboratory animals
expressed as percentage of cells with MHC-I co-localized with indicated compartment ± SEM of three independent experiments. The
number of cells counted per experimental group was 200. ***P<0.001 vs. IFN-γ-treated; ΔΔΔP<0.001 vs. the other subcellular
compartments.
https://doi.org/10.1371/journal.ppat.1006527.g007
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of the National Institutes of Health. Animal experiments were approved by the Animal Care
and Use Committee of the IMEX Institute. The protocol license number assigned by this Com-
mittee is: 020/2016.
Bacteria
B. abortus S2308, Salmonella typhimurium SL14028, Bacillus cereus B10502, Escherichia coli
11105 and Klebsiella pneumoniae 700603, and B. abortus RB51, B. abortus virB10, B. abortus
btpA, B. abortus btpB, B. abortus btpAbtpB or B. abortus Bpe159 mutant strains were cultured
in tryptose-soy agar supplemented with yeast extract (Merck). The number of bacteria on
Fig 8. B. abortus RNA degradation products are also able to retain MHC-I within the Golgi apparatus.
(A) Confocal micrographs of THP-1 cells treated with B. abortus RNA or RNase I-treated B. abortus RNA in
the presence of IFN-γ for 48 h. MHC-I expression was determined with a primary anti-human MHC-I Ab (W6/
32) and Alexa 546-labelled secondary Ab (red). Golgi apparatus was detected using a mAb specific for
GM130 followed by Alexa 488-labelled secondary Ab (green). White arrows show co-localization (yellow
staining). Cells treated only with RNase I were used as negative controls. Results are representative of three
independent experiments.
https://doi.org/10.1371/journal.ppat.1006527.g008
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stationary-phase cultures was determined by comparing the OD at 600 nm with a standard
curve. To obtain heat-killed B. abortus strains, bacteria were washed in PBS, heat killed at 70˚C
for 20 min and stored at -70˚C until used. Total absence of B. abortus viability subsequent to
heat killing was verified by the absence of bacterial growth in tryptose-soy agar. All live Bru-
cella manipulations were performed in biosafety level 3 facilities, located at the Instituto de
Investigaciones Biome´dicas en Retrovirus y SIDA (Buenos Aires, Argentina).
Fig 9. B. abortus RNA-mediated MHC-I inhibition correlates with diminished Ag presentation to MHC-I-restricted
CD8+ T cells. BMM from WT (A) and TLR7 KO (B) mice were treated with different doses of B. abortus RNA in the
presence of mIFN-γ for 48 h. Then cells were washed and incubated with 20 ng/ml of 257–264 OVA peptide (SIINFEKL)
for 20 min at 37˚C. BMM from WT (A) and TLR7 KO (B) mice were washed and cultured for 0, 4, 6 and 18 h at 37˚C with
B3Z cells, a T cell hybridoma specific for OVA-Kb, which carries a β-galactosidase construct driven by NF-AT elements
from the IL-2 promoter. T cell activation was measured using a colorimetric assay for LacZ activity with o-nitrophenyl-P-D-
galactoside as a substrate. Background absorbance values obtained for BMM cultured in the absence of OVA were
subtracted. ***P<0.001 vs. mIFN-γ-treated.
https://doi.org/10.1371/journal.ppat.1006527.g009
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Expression and purification of recombinant lipidated Omp19 (L-Omp19)
and unlipidated Omp19 (U-Omp19) from B. abortus
Lipoproteins were expressed and purified as previously described [19]. To eliminate LPS con-
tamination, recombinant Omps were adsorbed with Sepharose-polymyxin B (Sigma-Aldrich).
Both proteins contained less than 0.25 endotoxin U/μg of protein as assessed by Limulus Ame-
bocyte Lysate assay (Lonza). The protein concentration was determined by the BCA protein
assay (Pierce) using bovine serum albumin as standard. The purified proteins were aliquoted
and stored at -70˚C until used.
LPS and DNA from B. abortus
B. abortus 2308 LPS was provided by I. Moriyo´n (University of Navarra, Pamplona, Spain).
The purity and characteristics of these preparations have been described elsewhere [20]. LPS
was solubilized in water by sonication at the appropriate concentration and autoclaved before
use. B. abortus DNA was purified by extraction with phenol:chloroform:isoamyl alcohol and
ethanol precipitation [21]. To eliminate LPS contamination, DNA was adsorbed with Sephar-
ose-polymyxin B (Sigma-Aldrich). DNA contained less than 0.25 endotoxin U/μg of protein as
assessed by Limulus Amebocyte Lysate assay (Lonza).
Cells and media
All experiments were performed at 37˚C in 5% CO2 atmosphere and standard medium com-
posed of RPMI-1640 supplemented with 25 mM Hepes, 2 mM L-glutamine, 10% heat-inacti-
vated fetal bovine serum (Gibco), 100 U of penicillin/ml and 100 μg of streptomycin/ml. THP-
1 cells were obtained from the American Type Culture Collection (Manassas, VA) and cul-
tured as previously described [19]. To induce maturation, cells were cultured in 0.05 μM
1,25-dihydroxyvitamin D3 (EMD Millipore) for 72 h. Peripheral blood mononuclear cells
(PBMCs) were obtained by Ficoll-Hypaque (GE Healthcare) gradient centrifugation from
human blood collected from healthy adult individuals. Monocytes were then purified from
PBMCs by Percoll (GE Healthcare) gradient and resuspended in standard medium. Purity of
the isolated CD14+ monocytes was more than 80% as determined by flow cytometry. Viability
of cells was more than 95% in all the experiments as measured by trypan blue exclusion test.
Mouse bone marrow-derived macrophages (BMM) were generated by differentiation of bone
marrow progenitors from C57BL/6 wild type mice, TRIF KO or TLR7 KO mice (provided by
Federal University of Minas Gerais, Belo Horizonte, Brazil) with rM-CSF (PeproTech), as pre-
viously described [22].
In vitro infection
THP-1 cells at a concentration of 0.5 x 106/ml were infected in round-bottom polypropylene
tubes (Falcon) with different multiplicities of infection (MOI) of B. abortus S2308, B. abortus
RB51, B. abortus virB10, B. abortus btpA, B. abortus btpB, B. abortus btpAbtpB or B. abortus
Bpe159 mutants. All infections were done in the presence of 150 U/ml IFN-γ (Endogen) for 2
h in standard medium containing no antibiotics. In another set of experiments, BMM from
WT or TLR7 KO mice at a concentration of 0.5 x 106/ml were infected in a 24-well plate with
different MOI of B. abortus S2308. Infections were done in the presence of 10 ng/ml mIFN-γ
(Peprotech) for 2 h in standard medium containing no antibiotics. In all cases, cells were
extensively washed to remove uninternalized bacteria and infected cells were maintained in
culture in the presence of IFN-γ or mIFN-γ, 100 μg/ml gentamicin and 50 μg/ml streptomycin
for an additional 48 h.
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Apoptosis assay
For viability assay, THP-1 cells at a concentration of 0.5 x 106/ml were treated with different
doses of B. abortus RNA in the presence of IFN-γ for 48 h. THP-1 cells treated with 2% para-
formaldehyde (PFA) were also included as positive control. After 48 h, cells were washed and
incubated with Annexin V-FITC and Propidium Iodide (BD Biosciences) for 10 min on ice in
darkness. Then, cells were evaluated in the quadrants of Annexin V+/PI- (early apoptosis),
Annexin V+/PI+ (late apoptosis) and Annexin V-/PI+ (necrosis). After labelling, cells were ana-
lyzed on a FACSCalibur flow cytometer (BD Biosciences) and data were processed using Cell-
Quest software (BD Biosciences).
RNA preparation
5–10 x 106 PBMCs or 5 x 108 CFU were resuspended in 1ml of TRIzol Reagent (Invitrogen)
and total RNA was extracted according to the manufacturer’s instructions. OD at 260 was
measured for RNA quantification. In another set of experiments, B. abortus RNA was purified
with Quick-RNA MiniPrep (Zymo Research) according to the manufacturer’s instructions.
The purity of B. abortus RNA was assessed using a DeNovix DS-11 Spectrophotometer (DeNo-
vix Inc.) with a ratio of absorbance 260/280 > 2.0 and a ratio of absorbance 260/230 > 1.8. In
one set of experiments, RNA was treated with DNase RQ1 (Promega), Proteinase K (PK) (Pro-
mega) or E. coli RNase I (Life Technologies) prior to cell stimulation. RNA preparations (B.
abortus RNA, DNase-treated B. abortus RNA, PK-treated B. abortus RNA and RNase I-treated
B. abortus RNA) were further visualized by 1% agarose gel electrophoresis. The RNA was
detected using UV light and the size of the RNA was determined using standard 100 bp Plus
DNA ladder (TransGen Biotech Co., Ltd.).
In vitro stimulation
Cells at 0.5 x 106/ml were stimulated with B. abortus RNA, other prokaryotic or eukaryotic
RNAs, DNase-treated B. abortus RNA, PK-treated B. abortus RNA, RNase I-treated B. abortus
RNA, HK B. abortus strains, different structural components of B. abortus (LPS, DNA and
lipoproteins) or TLR ligands in the presence of 150 U/ml IFN-γ for 48 h in standard medium
containing antibiotics. In another set of experiments, THP-1 cells were treated with B. abortus
RNA complexed with Lipofectamine 2000 (Invitrogen). Briefly, Lipofectamine was mixed with
bacterial RNA (1:3 ratio) in 100 μL/well serum-free RPMI and incubated for 20 min at room
temperature. Then, complexes were added to the cells in the presence of 1.25% FBS and cell
cultures were incubated for 48 h at 37˚C in a 5% CO2 atmosphere. In all cases, MHC-I expres-
sion was evaluated by flow cytometry.
Flow cytometry
After B. abortus infection or stimulation; THP-1 cells or human primary monocytes were
stained with FITC-labelled anti-human HLA-ABC (clone G46-2.6; BD Pharmingen) or iso-
type-matched control mAbs. In the experiments with murine macrophages, BMM were
infected with B. abortus, or treated with B. abortus RNA or TLR ligands in the presence of 10
ng/ml recombinant murine IFN-γ (PeproTech) for 48 h. To determine MHC-I surface expres-
sion, cells were stained with PE- or FITC-labelled anti-mouse H-2Kd/H-2Dd (clone 34-1-2S;
BioLegend). In all cases, cells were washed and incubated with 7-Amino-Actimycin D
(7-AAD; BD Biosciences) for 10 min on ice in darkness. MHC-I expression was evaluated gat-
ing on viable cells (7-AAD negative cells). After labelling, cells were analyzed on a
B. abortus RNA inhibits MHC-I
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006527 August 2, 2017 18 / 27
FACSCalibur flow cytometer (BD Biosciences) and data were processed using CellQuest soft-
ware (BD Bioscience) or FlowJo 7.6 software.
Confocal microscopy
THP-1 cells were incubated in chambers-slides (2 x 105 cells/well) with 10 ng/ml PMA
(Sigma-Aldrich) for 24 h to promote adherence. Then, cells were infected with B. abortus or
stimulated with B. abortus RNA or RNase I-treated B. abortus RNA in the presence of IFN-γ
for 48 h, fixed with 2% paraformaldehyde, permeabilized with 0.1% saponin and incubated
with anti-HLA-ABC class I mAb W6/32, (purified from murine hybridoma culture superna-
tants) and Alexa 546-labelled secondary Ab (Invitrogen). Subcellular compartments were
detected using mAbs specific for EEA1 (early endosomes), LAMP-2 (late endosomes/lyso-
somes), GM130 (Golgi) and calnexin (ER) (BD Biosciences) following Alexa 488-labelled sec-
ondary Ab (Invitrogen). Slides were mounted with PolyMount (Polysciences) and analyzed
using FV-1000 confocal microscope with an oil-immersion Plan Apochromatic 60X NA1.42
objective (Olympus).
Ag cross-presentation assay
Presentation of OVA epitope 257–264 on Kb (SIINFEKL) was detected using the T cell hybrid-
oma B3Z, which carries a β-galactosidase construct driven by NF-AT elements from the IL-2
promoter [23]. For Ag presentation assays, B. abortus RNA-treated BMM from WT or TLR7
KO mice were exposed to 20 ng/ml of the SIINFEKL epitope during 20 min at 37˚C. Then
cells were washed, suspended in complete medium, and cultured in the presence of the T cell
hybridoma B3Z. After 0, 4, 6 and 18 h of culture, cells were washed with PBS, and the cross-
presentation was evaluated by a colorimetric assay using o-nitrophenyl-p-D-galactoside
(ONPG) (Sigma-Aldrich) as substrate to detect the LacZ activity in B3Z lysates.
Reagents
Antibody targeting EGFR (Cetuximab) was purchased from Merck Serono. Gardiquimod,
R848 (Resiquimod), ssRNA40/LyoVec and ORN06/LyoVec were purchased from InvivoGen.
The 257–264 OVA peptide (SIINFEKL) was provided by Dr. S. Amigorena (Institut Curie,
Paris, France). TLR3/dsRNA Complex Inhibitor was purchased from Calbiochem.
Measurement of cytokine concentrations
Human TNF-α and IL-1β were measured in culture supernatants by sandwich ELISA, using
paired cytokine-specific mAbs according to the manufacturer’s instructions (BD
Pharmingen).
Statistical analysis
Results were analyzed with one-way ANOVA followed by post hoc Tukey test using the Graph-
Pad Prism software.
Discussion
B. abortus is an intracellular pathogen capable of surviving inside macrophages [24]. The suc-
cess of B. abortus as a chronic pathogen relies on its ability to orchestrate different strategies to
evade the adaptive CD8+ T cells responses that it elicits. Previously, we have demonstrated that
B. abortus infection inhibits the IFN-γ-induced MHC-I surface expression on human mono-
cytes down-modulating cytotoxic CD8+ T cell responses [5]. Moreover, we have recently
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deepened into various aspects of this event, such as its kinetics and the participation of the
EGFR pathway [6]. Two striking features of the phenomenon of MHC-I inhibition allowed us
to shed light on the B. abortus components involved. First of all, heat-killed B. abortus is inca-
pable of inhibiting MHC-I expression [5]. Secondly, the phenomenon is triggered early during
infection [6]. Together, these results indicated that only metabolically active viable bacteria
can inhibit MHC-I expression and that it must occur during the time span before the bacteria
are removed and/or mediated by a product generated early in response to infection.
In this study, we could corroborate that what Brucella employs to inhibit MHC-I on mono-
cytes/macrophages is a component associated with bacterial viability itself regardless of the
most relevant bacterial virulence factors. Particularly, we elucidated that this component is B.
abortus RNA. Moreover, our experiments demonstrated that not only wild-type B. abortus
RNA but also the RNA of two mutants strains, RB51 and virB10, were equally able to inhibit
MHC-I. These results together with those shown in Fig 1 and S1 Fig corroborate that what the
cells sense is a general determinant of bacterial viability different from its virulence factors.
Supporting these results, we demonstrated that the inability of heat-killed B. abortus to inhibit
MHC-I surface expression is due to the absence of RNA in these bacterial preparations. In line
with this evidence, it is widely known that live vaccines trigger more vigorous immune
responses than their killed counterparts, even when live microorganisms are attenuated by
elimination of their virulence factors [25]. Since structural bacterial components are present in
both live and dead microorganisms, this suggested that there should be non-characterized
determinants in live bacteria important for the induction of an effective protective immune
response. In this sense, it has been demonstrated that macrophages can directly sense micro-
bial viability through detection of prokaryotic messenger RNA (mRNA), a vita-PAMP present
only in viable bacteria, triggering a unique innate and a robust adaptive antibody responses
[10]. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far
considered to be reserved for pathogenic bacteria, but Sander et al in their study show that
even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided they are
alive [10]. Furthermore, our results also demonstrated that inhibition of MHC-I is not
restricted to B. abortus as it could be extended to other prokaryotic RNAs, suggesting the
broad implications of this immune regulation in the context of other infectious processes.
One issue that merits discussion is how, during B. abortus infection, the human mono-
cyte/macrophages are able to sense bacterial RNA. This question can be answered if we
review the biology of B. abortus and the localization of receptors capable of detecting RNA. It
has been described that viral and bacterial RNA are sensed by pattern recognition receptors
(PRRs), among which the TLRs family has gained more attention [26, 27]. TLR3, TLR7 and
TLR8 are the ones preferentially expressed in intracellular vesicles of the endoplasmic reticu-
lum (ER), endosomes, and lysosomes [28]. With respect to the intracellular cycle of the
bacterium, B. abortus is able to enter, survive and replicate within vacuolar phagocytic com-
partments of macrophages [29]. Once inside the macrophages, Brucella dwells in an acidified
compartment that fuses with components of the early and late endosomal/lysosomes pathway
[7, 30]. There, the vast majority of the ingested bacteria are rapidly killed. However, the estab-
lishment of a persistent infection depends on the ability of the bacterium to form a Brucella-
containing vacuole (BCV), which traffics from the endocytic compartment to the endoplas-
mic reticulum (ER) [7, 29, 31]. Once inside the replicative BCV, bacteria are resistant to fur-
ther attack and begin to multiply dramatically [7, 31]. Starr et al demonstrated that Brucella
replication in the ER is followed by BCV conversion into multi-membrane LAMP-1-positive
vacuoles with autophagic features (aBCV). Furthermore, aBCVs were required to complete
the intracellular Brucella lifecycle and for cell-to-cell spreading [32]. In this context, it is pos-
sible that while B. abortus traffics through early and late endosomes/lysosomes the bacterial
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RNA released during phagocytosis activate endolysosomal TLRs. On the other hand, B. abor-
tus mutant strains on virulence factors are also capable of infecting human monocytes/mac-
rophages and transiting by early and late endosomes/lysosomes, but, unlike wild-type B.
abortus, they are unable to replicate in BCVs and thus persist into the cell host. However, our
results demonstrated that these strains are equally able to down-regulate MHC-I than wild-
type B. abortus. As a consequence, the RNA of these bacteria could also gain access to TLR3,
TLR7 or TLR8 in their transit through endosomes and lysosomes, although they do not per-
sist in macrophages. In accordance with this, it was reported that human TLR8 is activated
upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes [33].
Furthermore, in line with endosomal TLRs sensing in an infectious context, we have previ-
ously demonstrated that MHC-I inhibition is an early event during infection, already
observed at 8 h post-infection [6]. This goes along with the time that elapses in the passage of
the bacteria by the early and late endocytic/lysosomal pathway [30]. In our in vitro experi-
ments of stimulation with purified RNA, either in the presence or the absence of transfection,
the entry of RNA by endocytosis gaining access to the endosomal TLRs can perfectly mimic
what happens in an infectious context.
Regarding the receptor involved, our results indicated that an hTLR7/8 agonist such as
R848 was able to mimic the MHC-I inhibition mediated by B. abortus RNA. However, an
hTLR7 agonist per se was unable to reproduce MHC-I inhibition. This led us to propose
hTLR8 as a possible receptor, which was corroborated by the specific human TLR8 agonists
ssRNA40 and ORN06. The greater efficiency of the synthetic oligonucleotide ORN06 in
MHC-I inhibition may be due to the fact that it contains 6 repeats of the UUGU sequence
motif, identified as the minimal motif responsible for ssRNA40 immunoactivity [34]. In addi-
tion, the involvement of hTLR8 in the B. abortus RNA-mediated MHC-I inhibition was cor-
roborated in murine BMM using the agonist ssRNA40 which is also specific for murine TLR7,
since TLR7 acts as the human TLR8 in mice [17, 18]. Moreover, our results with BMM from
TLR7 KO mice confirm that the inhibition of MHC-I surface expression by B. abortus and its
RNA is mediated by hTLR8/mTLR7. In agreement with these results, the inhibition of antigen
presentation to CD8+ T cells by B. abortus RNA was abolished in BMM from TLR7 KO mice.
Further experiments in vivo are needed to determine the involvement of TLR8/TLR7 in the
cytotoxic CD8+ T cell responses and chronicity of B. abortus-infected mice.
Single-stranded RNA has been identified as the natural ligand of TLR7 and TLR8 [17, 35].
Of note, a recent report identifying the molecular structure of TLR8 showed that this receptor
recognizes degradation products of RNA, specifically an uridine mononucleoside at one bind-
ing site and oligonucleotides like UG or UUG at a distinct second binding site [14]. The
concept of recognition of RNA degradation products by TLR8 raises the hypothesis that phos-
phatases and/or nucleases of bacterial or host origin might play a role upstream of TLR8 acti-
vation [36], in analogy to the requirement for lysosomal endonuclease DNase II for the
activation of TLR9 [37, 38]. In agreement with this evidence, we could observe that RNA
digested by a specific prokaryotic RNase was able to inhibit MHC-I in the same manner as
intact RNA. These results indicate that these degradation products could be sensed by TLR8.
Although our results indicated that human TLR3 and TLR7 are not involved in MHC-I
inhibition, Campos et al have recently demonstrated that both receptors play an important role
in sensing B. abortus RNA to induce the production of pro-inflammatory cytokines and type I
IFN expression in murine DCs. However, these receptors were not required to control Brucella
infection in vivo [39]. To explain the latter, they hypothesized that TLR13, a PRR involved in
sensing a specific sequence from bacterial 23S rRNA [40, 41], could play a role in B. abortus
RNA sensing. However, we did not focus our attention on TLR13 since it is a receptor present
in mice but not in humans [40, 41]. Beyond TLRs, RIG-I and MDA5 have been characterized
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as cytosolic receptors capable of sensing RNA. More specifically, MDA5 was identified to initi-
ate antiviral signaling in response to long stretches of viral double-stranded RNA, whereas
RIG-I is a sensor of short double-stranded or single-stranded RNA with 5’-triphosphate ter-
mini [42, 43]. Moreover, RIG-I was also involved in the recognition of bacterial RNA. It has
been demonstrated that RIG-I detects infection with live Listeria monocytogenes by sensing the
RNA secreted into the cytosol of infected cells [44, 45]. Although RIG-I and MDA5 could also
be involved in the MHC-I inhibition mediated by B. abortus RNA, taking into account the
cytosolic location of such receptors, the RNA should be able to be transferred from the phago-
somes into the cell cytosol. However, this does not occur for all bacteria as it was demonstrated
for B. burgdorferi RNA [33]. Regarding Brucella, it was demonstrated that B. abortus DNA can
activate cytosolic molecules such as AIM2 and STING [46, 47]; however, whether RNA might
gain access to cytosolic receptors during phagocytosis has not been investigated yet.
We have previously demonstrated that the EGFR pathway is involved in the inhibition of
MHC-I mediated by B. abortus infection [6]. Moreover, that EGF and TGF-α are EGF-like
ligands involved in the phenomenon of MHC-I inhibition [6]. In light of the results that we
obtained in this study and those recently published [6], we next investigated if there was a con-
nection between RNA sensed by TLR8 and the EGFR pathway. EGFR neutralization with
Fig 10. Proposed model for the MHC-I surface down-regulation mechanism mediated by B. abortus. 1. Infection of human
monocytes/macrophages with B. abortus induces the release of its RNA and RNA degradation products into the Brucella-containing
endosomes. 2. These molecules via TLR8 induce the secretion of EGF-like ligands such as EGF and TGF-αwhich bind ErbB receptors on
the cell surface causing their activation. 3. These effects finally cause the retention of MHC-I molecules within the Golgi apparatus. 4. MHC-I
molecules are therefore unable to reach the cell surface and present bacterial Ags to CD8+ T cells. 5. Inhibition of Ag presentation enables
the bacteria to hide inside human monocytes/macrophages and avoid the cytotoxic CD8+ T cell responses.
https://doi.org/10.1371/journal.ppat.1006527.g010
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Cetuximab led to a partial reversion of the TLR8 agonist mediated-MHC-I inhibition suggest-
ing a clear connection between the TLR8 and EGFR pathways. To our knowledge, this is the
first report describing a link between these pathways.
Overall, the results obtained in this study support a model in which infection with B. abor-
tus induces the release of its RNA and RNA degradation products into the Brucella-containing
endosomes. These molecules via TLR8 induce the secretion of EGF-like ligands such as EGF
and TGF-α which bind ErbB receptors on the cell surface causing their activation. These
effects finally lead to the retention of MHC-I molecules within the Golgi apparatus. MHC-I
molecules are therefore unable to reach the cell surface and present bacterial Ags to CD8+ T
cells (Fig 10).
Here we elucidate that the vita-PAMP RNA is a component employed by B. abortus to
inhibit MHC-I expression, an event whereby the bacteria could avoid the cytotoxic CD8+ T
cell immunological surveillance establishing a chronic infection.
Supporting information
S1 Fig. Only viable B. abortus, independently of its virulence factors, is able to inhibit
MHC-I expression. (A and B, Panels i and iii) THP-1 cells were infected with B. abortus RB51
(A) or virB10- (B) at different MOI in the presence of IFN-γ for 2 h, washed and cultured in
the presence of IFN-γ for 48 h. (A and B, Panels ii and iv) At the same time, heat-killed bacteria
(HK) were used to treat THP-1 cells in the presence of IFN-γ for 48 h. MHC-I expression was
assessed by flow cytometry. Bars represent the arithmetic means ± SEM of five experiments.
MFI, mean fluorescence intensity. P<0.001 vs. IFN-γ-treated.
(TIF)
S2 Fig. MiniPrep-purified B. abortusRNA is also able to down-modulate MHC-I. THP-1
cells were treated with different doses of B. abortus RNA purified with Quick-RNA MiniPrep
kit in the presence of IFN-γ for 48 h. MHC-I expression was assessed by flow cytometry. Bars
indicate the arithmetic means ± SEM of five independent experiments. MFI, mean fluores-
cence intensity. P<0.01 vs. IFN-γ-treated.
(TIF)
S3 Fig. RNA is absent in heat-killed B. abortus. (A) RNA was purified from B. abortus or
HKBA. In addition, B. abortus RNA was heat-treated at 70˚C for 20 min. Each preparation
was visualized by 1% agarose gel electrophoresis. (B) THP-1 cells were stimulated with B. abor-
tus RNA, RNA extraction products from HKBA or heat-treated B. abortus RNA in the pres-
ence of IFN-γ for 48 h. MHC-I expression was assessed by flow cytometry. Bars represent the
arithmetic means ± SEM of three experiments. MFI, mean fluorescence intensity. P<0.01 vs.
IFN-γ-treated.
(TIF)
S4 Fig. B. abortusRNA complements its absence in HKBA, making it capable of down-
modulating MHC-I. THP-1 cells were treated with HKBA with or without B. abortus RNA in
the presence of IFN-γ for 48 h. MHC-I expression was assessed by flow cytometry. Bars indi-
cate the arithmetic means ± SEM of five independent experiments. MFI, mean fluorescence
intensity. P<0.01 vs. IFN-γ-treated.
(TIF)
S5 Fig. Nystatin reversed MHC-I inhibition mediated by B. abortusRNA. THP-1 cells were
treated with B. abortus RNA (10 μg/ml) in the presence of IFN-γ and in the presence or
absence of an endocytosis inhibitor (Nystatin) for 48 h. MHC-I expression was assessed by
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flow cytometry. Bars indicate the arithmetic means ± SEM of five independent experiments.
MFI, mean fluorescence intensity. P<0.05 vs. IFN-γ-treated; ## P<0.01 vs. Control.
(TIF)
S6 Fig. Other prokaryotic but not eukaryotic RNAs are also able to inhibit IFN-γ-induced
MHC-I expression. (A-D) THP-1 cells were treated with different doses of S. typhimurium
(A), B. cereus (B), E. coli (C) or K. pneumoniae (D) RNAs in the presence of IFN-γ for 48 h.
(E) THP-1 cells were treated with different doses of PBMCs RNA in the presence of IFN-γ
for 48 h. MHC-I expression was assessed by flow cytometry. Bars indicate the arithmetic
means ± SEM of three independent experiments. MFI, mean fluorescence intensity. P<0.05;
P<0.01; P<0.001 vs. IFN-γ-treated.
(TIF)
S7 Fig. Cetuximab does not affect the functionality of TLR8. (A and B) THP-1 cells were
treated with ORN06 or B. abortus RNA in the presence of Cetuximab or Isotype control for 24
h. Supernatants were then collected and the amount of TNF-α (A) or IL-1β (B) was deter-
mined by ELISA. Bars indicate the arithmetic means ± SEM of three independent experiments.
P<0.001 vs. untreated + Isotype or Cetuximab, accordingly.
(TIF)
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